Nasdaq : Stockholm Welcomes XVIVO Perfusion to the Main Market

Stockholm, November 28, 2016- Nasdaq (Nasdaq: NDAQ) announced that XVIVO Perfusion AB (short name: XVIVO), a Mid Cap company within the Healthcare sector, has started trading of its shares on the main market of Nasdaq Stockholm. XVIVO Perfusion is the 75company to list at Nasdaq's Nordic markets* in 2016.

XVIVO Perfusion is a medical technology company headquartered in Gothenburg, Sweden, with presence Lund, Sweden and in Denver, USA. The company is rooted in medical science and its core business is in organ preservation before transplantation. XVIVO Perfusion focuses on developing optimized solutions for organ and tissue preservation and perfusion in connection with transplantation. They have more than 15 years of transplant industry experience and are marketing their products worldwide. XVIVO Perfusion is dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation. For more information, please visitwww.xvivoperfusion.com

'Our vision is that 'no patient should have to die waiting for an organ'. The entrance to the main market of Nasdaq Stockholm is a step to further strengthen our shareholder base. This will secure that we can follow through in taking our promising product development projects through regulatory approval and to the market to the benefit of patients waiting for an organ.' says Magnus Nilsson, CEO of XVIVO Perfusion AB.

'We welcome XVIVO Perfusion to our main market, where they will make a compelling addition to our healthcare sector' said Adam Kostyál, senior vice president and head of European listings at Nasdaq. 'XVIVO is an innovative company doing important work, and we look forward to continue supporting them as a publicly traded company.'

*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.

About Nasdaq
Nasdaq (Nasdaq: NDAQ) is a leading provider of trading, clearing, exchange technology, listing, information and public company services across six continents. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to more than 3,700 listed companies with a market value of over $10.0 trillion and nearly approximately 18,000 corporate clients. To learn more, visitnasdaq.com/ambitionorbusiness.nasdaq.com.

Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.